Recruitment Temporarily Suspended Into C.E.R.A. Phase II Oncology Trial
Mon, 26 Feb 2007 08:00 AM EST
... Roche announced today that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy. [click link for full article] ...
Related Topics
- Clinical Trials
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Kniest dysplasia
- Cancer
- Juvenile Diabetes
- Phenylephrine and Guaifenesin Capsules
- Cockayne Syndrome Type II
- Pena Shokeir II Syndrome
- Ramsay Hunt Syndrome Type II
- Tysabri
- Pseudoephedrine and Guaifenesin ER
- Collagenopathy, types II and XI
- Radiotherapy
- Desipramine
- Trastuzumab
- Radiation
- Herpes Simplex
- Eletriptan

Not Signed In -


